| ISIN | CH0414176773 |
|---|---|
| Valor Number | 41417677 |
| Bloomberg Global ID | |
| Fund Name | Swisscanto (CH) Equity Fund Sustainable Switzerland NT CHF |
| Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
| Fund Provider | Swisscanto Fondsleitung AG |
| Representative in Switzerland | |
| Distributor(s) | Schweizerische Kantonalbanken |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | Special conditions apply to the issue of units |
| Redemption Condition | Special conditions apply to the redemption of units |
| Investment Strategy *** | Das Anlageziel des Teilvermögens besteht hauptsächlich darin, einen langfristigen Kapitalzuwachs verbunden mit angemessenen Erträgen zu erzielen und die Performance eines im Prospekt spezifizierten Benchmarks (der Referenzindex) durch aktives Management zu übertreffen. Die Fondsleitung bietet nicht Gewähr dafür, dass dieses Anlageziel auch erreicht wird. |
| Peculiarities |
| Current Price * | 142.60 CHF | 20.11.2025 |
|---|---|---|
| Previous Price * | 142.02 CHF | 19.11.2025 |
| 52 Week High * | 149.90 CHF | 13.02.2025 |
| 52 Week Low * | 124.53 CHF | 09.04.2025 |
| NAV * | 142.60 CHF | 20.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 770,008,239 | |
| Unit/Share Assets *** | 756,473,419 | |
| Trading Information SIX | ||
| YTD Performance | +5.71% |
31.12.2024 - 20.11.2025
31.12.2024 20.11.2025 |
|---|---|---|
| 1 month | -1.40% |
20.10.2025 - 20.11.2025
20.10.2025 20.11.2025 |
| 3 months | -1.86% |
20.08.2025 - 20.11.2025
20.08.2025 20.11.2025 |
| 6 months | -2.08% |
20.05.2025 - 20.11.2025
20.05.2025 20.11.2025 |
| 1 year | +6.29% |
20.11.2024 - 20.11.2025
20.11.2024 20.11.2025 |
| 2 years | +15.26% |
20.11.2023 - 20.11.2025
20.11.2023 20.11.2025 |
| 3 years | +11.56% |
21.11.2022 - 20.11.2025
21.11.2022 20.11.2025 |
| 5 years | +18.77% |
20.11.2020 - 20.11.2025
20.11.2020 20.11.2025 |
| Equity Participation Rate in % | 99.66 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nestle SA | 10.45% | |
|---|---|---|
| Roche Holding AG | 10.13% | |
| Novartis AG Registered Shares | 9.36% | |
| ABB Ltd | 7.27% | |
| Zurich Insurance Group AG | 5.91% | |
| UBS Group AG Registered Shares | 5.28% | |
| Compagnie Financiere Richemont SA Class A | 4.55% | |
| Lonza Group Ltd | 3.41% | |
| Givaudan SA | 3.27% | |
| Swiss Re AG | 2.96% | |
| Last data update | 31.10.2025 | |
| TER | 0.00% |
|---|---|
| TER date | 31.10.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | |
| Ongoing Charges *** | 0.00% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |